Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health - Top-Institutions - MDSpire

Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health

  • By

  • Chi-Hsien Lee

  • Thi Phuong Nam Bui

  • Camille Petitfils

  • Ching Jian

  • Giselle C Wong

  • Anthony Puel

  • Tiphaine Le Roy

  • Samuel Bellais

  • Bouthaina Ben Abdallah

  • Mélanie Nehlich

  • Thomas Leicht

  • Manyi Jia

  • Lesley Hoyles

  • Massimo Federici

  • Jose Manuel Fernández-Real

  • Remy Burcelin

  • Marc-Emmanuel Dumas

  • Nathalie M Delzenne

  • Thomas Clavel

  • Sjef Boeren

  • Antonio Dario Troise

  • Andrea Scaloni

  • Giulio G Muccioli

  • Willem M De Vos

  • Matthias Van Hul

  • Patrice D Cani

  • July 1, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Gastroenterology
    • Hepatology

  • #2

    Cedars-Sinai Medical Center
    Cedars-Sinai Medical Center

    Los Angeles, California

    Key Differentiators

    • Gastroenterology
    • GI Surgery

  • #3

    Shiga University of Medical Science
    Shiga University of Medical Science

    Shiga, Japan

    Key Differentiators

    • Gastroenterology

  • #4

    Poznan University of Medical Sciences
    Poznan University of Medical Sciences

    Poznan, Poland

    Key Differentiators

    • Gastroenterology

Original Source(s)

Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health

  • by Chi-Hsien Lee, Thi Phuong Nam Bui, Camille Petitfils, Ching Jian, Giselle C Wong, Anthony Puel, Tiphaine Le Roy, Samuel Bellais, Bouthaina Ben Abdallah, Mélanie Nehlich, Thomas Leicht, Manyi Jia, Lesley Hoyles, Massimo Federici, Jose Manuel Fernández-Real, Remy Burcelin, Marc-Emmanuel Dumas, Nathalie M Delzenne, Thomas Clavel, Sjef Boeren, Antonio Dario Troise, Andrea Scaloni, Giulio G Muccioli, Willem M De Vos, Matthias Van Hul, Patrice D Cani

  • July 1, 2026

Related Content

Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial

Histopathological Findings in Sleeve Gastrectomy Specimens: Prevalence, Determinants, and Clinical Implications in a Large Brazilian Cohort

Excluded-stomach Perforation after Roux-en-Y and One-anastomosis Gastric Bypass: A Systematic Review with Video-illustrated Case Report